Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus Types I and II
Location: United States, AZ
Diabetes treated with Lantus, meal time insulin and metformin
6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® both plus Mealtime Insulin in Patients with Type 2 Diabetes Mellitus with a 6-month Safety Extension Period
Patient Inclusion Criteria:
Patient Exclusion Criteria:
Date Last Changed:
July 18, 2013
Brian Latham, Recruitment SpecialistClinical Research Advantage, Inc.East Valley Family Physicians
1455 W. Chandler Blvd, Building A Suite 1Chandler, AZ 85224Phone: 480-305-5701Fax: 480-820-5656
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.